Series: Rebates for Physician-Administered and Pharmacy Drug Claims

OBJECTIVE

States are generally required to collect rebates on physician-administered and pharmacy drugs in order to receive Federal matching funds for those drugs.  Previous OIG work identified significant concerns with States' efforts in obtaining rebates for physician-administered drug claims. We will follow-up with select States to determine whether States have implemented controls to ensure ongoing compliance with Federal Medicaid drug rebate requirements.

There are 5 projects in this series.

Project titles will remain unpublished until projects are complete and reports are posted.

ACTIVE PROJECTS IN THIS SERIES (5)

Project OAS-26-07-009 • Announced on Oct 22, 2025

Project OAS-26-07-010 • Announced on Oct 22, 2025

Project OAS-26-06-059 • Announced on Mar 2, 2026

Project OAS-26-06-058 • Announced on Mar 3, 2026

Project OAS-26-07-067 • Announced on Mar 25, 2026

TIMELINE

• October 22, 2025
  Series Number SRS-A-26-002 Assigned
• October 22, 2025
  Projects Announced

  Project OAS-26-07-009

• Project OAS-26-07-010

• March 2, 2026
  Project Announced

  Project OAS-26-06-059

• March 3, 2026
  Project Announced

  Project OAS-26-06-058

• March 25, 2026
  Project Announced

  Project OAS-26-07-067

• Today
  5 Projects In-Progress
• Est FY2027
  Estimated Fiscal Year for Series Completion

---